MENU

MS & Immune Disorders

About this condition
Patient & Caregiver Tools
Show More
Articles

News

07.06.20

The Women Neurologist Group and the Alliance for Advancement of Neuroscience Advocate for Continued use of Telemedicine 
  • KEYWORDS:
  • Alzheimer Disease
  • Epilepsy
  • Multiple sclerosis
  • Practice management
  • Sleep
  • Stroke

News

06.22.20

Enrollment Begins for Phase 1b Clinical Trial of T-cell Immunotherapy for Progressive Multiple Sclerosis 
  • KEYWORDS:
  • allogeneic EBV T-cell immunotherapy
  • ATA188
  • Multiple sclerosis

News

06.12.20

FDA Approves Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder
  • KEYWORDS:
  • FDA Approvals
  • Inebilizumab
  • neuromyelitis optica spectrum disorder
  • NMOSD

News

06.09.20

Phase 3 Trial of MSC-NTF Stem Cells for ALS Receives Continued Funding 
  • KEYWORDS:
  • Amyotrophic Lateral Sclerosis
  • MSC-NTF
  • NurOwn
Multiple Sclerosis Minute: The Central Vein Sign in Diagnosis of Multiple Sclerosis image

Columns

Multiple Sclerosis Minute: The Central Vein Sign in Diagnosis of Multiple Sclerosis

More accurate diagnosis is needed for multiple sclerosis and the central vein sign may be the needed imaging biomarker.

Marwa Kaisey, MD, and Nancy L. Sicotte MD, FAAN

News

06.01.20

Ozanimod, a New Oral Treatment for Relapsing Multiple Sclerosis, Now Available
  • KEYWORDS:
  • Multiple sclerosis
  • Ozanimod
  • Relapsing Multiple Sclerosis

News

05.28.20

FDA Removes Category C Warning of Possible Risk in Pregnancy and Breast Feeding for MS Treatment Interferon Beta-1a 
  • KEYWORDS:
  • Interferon beta
  • Multiple sclerosis
  • Pregnancy
  • Relapsing Multiple Sclerosis

News

05.24.20

T-Cell Immunotherapy for Progressive MS Shows Safety and Efficacy
  • KEYWORDS:
  • Multiple sclerosis
  • Secondary progressive multiple sclerosis

News

05.23.20

Continued Safety and Tolerability of Satralizumab for NMOSD
  • KEYWORDS:
  • neuromyelitis optica spectrum disorder
  • NMOSD
  • Satralizumab

News

05.23.20

Evobrutinib Treatment Reduced Annualized Relapse Rate Sustained in Open-Label Extension Study
  • KEYWORDS:
  • Evobrutinib
  • Meeting coverage
  • Multiple sclerosis
  • Relapsing Multiple Sclerosis

News

05.07.20

New Social Networking Platform for the Multiple Sclerosis Community
  • KEYWORDS:
  • Multiple sclerosis
  • Relapsing Multiple Sclerosis
Neuroschistosomiasis image

Case Report

Neuroschistosomiasis

Complete neurologic recovery after acute cauda equina syndrome

Paul M. Elsbernd, MD; Kathryn J. Lago, DO; Tatjana P. Calvano, DO; and John H. Sladky, MD

April 2020 teaser

Cover Focus

Giant Cell Arteritis

Headache occurs in 70% to 80% of people with giant cell arteritis.

Britany Klenofsky, MD, and Huma U. Sheikh, MD

Diagnosing Secondary Headaches image

Cover Focus

Diagnosing Secondary Headaches

The SNOOP10 mnemonic is a useful framework for diagnosing secondary headaches.

Chia-Chun Chiang, MD, and Juliana VanderPluym, MD, FRCP, FAHS

April 2020 teaser

Guest Medical Editor's Page

Secondary Headaches

A guide to navigating the waters of headache evaluation.

Rashmi B. Halker Singh, MD, FAHS, FAAN

News

04.28.20

Data Show Ocrelizumab Reduces Disability Progression and Disease Risk in MS 
  • KEYWORDS:
  • Multiple sclerosis
  • Ocrelizumab
  • Relapsing Multiple Sclerosis
This Month's Issue
Clinical Trials for Huntington Disease

Natalia P. Rocha, PharmD, MSc, PhD; Gabriela D. Colpo, PhD; Antonio L. Teixeira, MD, PhD, MSc; and Erin Furr Stimming, MD

Hyperammonemic Crisis

Allie Massaro, MD

Neuromuscular Notes: Neuromuscular Ultrasound in Polyneuropathy

Michael S. Cartwright, MD, MS, and Hwajin Lee, MD